Senate Options Include Barring CER’s “Fast Track” To Coverage
Executive Summary
Senate Finance Committee Chairman Max Baucus, D-Mont., is trying to keep comparative effectiveness on track as part of health reform legislation, but options under the panel's consideration demonstrate that the role of cost in the evaluations is still a worry
You may also be interested in...
House Comparative Effectiveness Bill Includes “Physician Out” Clause
A group of moderate House Democrats introduced legislation on comparative effectiveness research May 19 that includes new language aimed specifically at limiting the influence of CER on physician prescribing
House Comparative Effectiveness Bill Includes “Physician Out” Clause
A group of moderate House Democrats introduced legislation on comparative effectiveness research May 19 that includes new language aimed specifically at limiting the influence of CER on physician prescribing
Obama Medicaid Rebate Provisions Make Way Into Finance Cmte. Options
The Senate Finance Committee is looking to the pharmaceutical industry to contribute to paying for health care reform in the form of adjustments to Medicaid rebates and the introduction of means testing in Medicare Part D